Check out SPECTRA member Dr Lai-Shan Tam from The Chinese University of Hong Kong’s recent publication “Effects of RANKL inhibition on promoting healing of bone erosion in rheumatoid arthritis using HR-pQCT: a 2-year, randomised, double-blind, placebo-controlled trial" in Annals of the Rheumatoid Diseases.
Comments